735064002: Bismuth subcitrate potassium (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Bismuth compound\Bismuth subcitrate potassium (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Metal and/or metal compound\Heavy metal and/or heavy metal compound\Bismuth and/or bismuth compound\Bismuth compound\Bismuth subcitrate potassium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3512962014 Bismuth subcitrate potassium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3512963016 Bismuth subcitrate potassium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

35301000188112 bismuth subcitrate potassium fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

795191000172114 subcitrate potassium de bismuth fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bismuth subcitrate potassium (substance)	Is a	Bismuth compound	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing bismuth subcitrate potassium (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	1
Product containing bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	3
Product containing only bismuth subcitrate potassium (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	1
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	3
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	3
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bismuth subcitrate potassium (substance)	Inferred relationship	Some	3

This concept is not in any reference sets